Japan
· Delayed Price · Currency is JPY Genetec Statistics
Total Valuation
Genetec has a market cap or net worth of JPY 5.89 billion. The enterprise value is 5.55 billion.
| Market Cap | 5.89B |
| Enterprise Value | 5.55B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Genetec has 11.46 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 11.46M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 71.58% |
| Owned by Institutions (%) | n/a |
| Float | 2.43M |
Valuation Ratios
The trailing PE ratio is 13.98.
| PE Ratio | 13.98 |
| Forward PE | n/a |
| PS Ratio | 0.73 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 4.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.02 |
| EV / Sales | 0.69 |
| EV / EBITDA | 6.21 |
| EV / EBIT | 7.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.86 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.22 |
| Debt / FCF | n/a |
| Interest Coverage | 83.78 |
Financial Efficiency
Return on equity (ROE) is 20.35% and return on invested capital (ROIC) is 15.63%.
| Return on Equity (ROE) | 20.35% |
| Return on Assets (ROA) | 11.02% |
| Return on Invested Capital (ROIC) | 15.63% |
| Return on Capital Employed (ROCE) | 26.50% |
| Revenue Per Employee | 23.18M |
| Profits Per Employee | 1.23M |
| Employee Count | 347 |
| Asset Turnover | 1.88 |
| Inventory Turnover | 22.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.96% in the last 52 weeks. The beta is 0.81, so Genetec's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -46.96% |
| 50-Day Moving Average | 507.88 |
| 200-Day Moving Average | 582.09 |
| Relative Strength Index (RSI) | 50.71 |
| Average Volume (20 Days) | 23,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genetec had revenue of JPY 8.04 billion and earned 426.00 million in profits. Earnings per share was 36.78.
| Revenue | 8.04B |
| Gross Profit | 3.28B |
| Operating Income | 754.00M |
| Pretax Income | 709.00M |
| Net Income | 426.00M |
| EBITDA | 893.00M |
| EBIT | 754.00M |
| Earnings Per Share (EPS) | 36.78 |
Balance Sheet
The company has 1.43 billion in cash and 1.09 billion in debt, giving a net cash position of 343.00 million or 29.93 per share.
| Cash & Cash Equivalents | 1.43B |
| Total Debt | 1.09B |
| Net Cash | 343.00M |
| Net Cash Per Share | 29.93 |
| Equity (Book Value) | 2.19B |
| Book Value Per Share | 191.13 |
| Working Capital | 1.44B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 40.79%, with operating and profit margins of 9.38% and 5.30%.
| Gross Margin | 40.79% |
| Operating Margin | 9.38% |
| Pretax Margin | 8.82% |
| Profit Margin | 5.30% |
| EBITDA Margin | 11.10% |
| EBIT Margin | 9.38% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 22.50, which amounts to a dividend yield of 4.41%.
| Dividend Per Share | 22.50 |
| Dividend Yield | 4.41% |
| Dividend Growth (YoY) | 0.93% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.58% |
| Shareholder Yield | 4.99% |
| Earnings Yield | 7.23% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 28, 2023. It was a forward split with a ratio of 3.
| Last Split Date | Dec 28, 2023 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genetec has an Altman Z-Score of 5.15.
| Altman Z-Score | 5.15 |
| Piotroski F-Score | n/a |